VANGUARD GROUP INC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 100 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$69,108,972
+43.1%
3,014,568
+2.9%
0.00%
+100.0%
Q2 2023$48,306,284
+2.3%
2,929,429
+10.6%
0.00%0.0%
Q1 2023$47,242,747
-37.5%
2,648,136
+2.0%
0.00%
-50.0%
Q4 2022$75,604,665
+38.1%
2,596,314
+16.2%
0.00%0.0%
Q3 2022$54,739,000
+513.5%
2,234,272
+3.9%
0.00%
Q2 2022$8,922,000
-65.7%
2,149,726
-4.8%
0.00%
-100.0%
Q1 2022$26,001,000
+12.1%
2,257,020
-2.9%
0.00%0.0%
Q4 2021$23,188,000
-23.2%
2,323,521
+0.5%
0.00%0.0%
Q3 2021$30,209,000
-31.7%
2,313,078
+2.5%
0.00%0.0%
Q2 2021$44,200,000
-7.7%
2,257,422
+0.2%
0.00%0.0%
Q1 2021$47,908,000
-14.5%
2,252,395
+19.5%
0.00%
-50.0%
Q4 2020$56,056,000
+36.8%
1,885,524
-0.3%
0.00%
+100.0%
Q3 2020$40,980,000
-6.8%
1,891,038
-4.1%
0.00%
-50.0%
Q2 2020$43,954,000
+68.8%
1,971,023
+15.2%
0.00%
+100.0%
Q1 2020$26,039,000
-32.5%
1,710,813
+1.9%
0.00%0.0%
Q4 2019$38,561,000
+39.6%
1,679,473
+31.3%
0.00%0.0%
Q3 2019$27,620,000
+5.7%
1,279,279
+7.8%
0.00%0.0%
Q2 2019$26,120,000
-17.3%
1,187,260
+3.1%
0.00%0.0%
Q1 2019$31,575,000
+8.5%
1,151,990
+6.4%
0.00%0.0%
Q4 2018$29,096,000
-4.8%
1,082,465
+3.3%
0.00%0.0%
Q3 2018$30,575,000
+4.8%
1,048,186
+12.3%
0.00%0.0%
Q2 2018$29,166,000
+263.8%
933,009
+131.6%
0.00%
Q1 2018$8,018,000
-42.2%
402,912
-15.6%
0.00%
-100.0%
Q4 2017$13,875,000477,4330.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders